Cytosorbents Corp reports results for the quarter ended September 30 - Earnings Summary

Cytosorbents

13/11/2026 24:27

Cytosorbents Corp CTSO.OQ reported a quarterly adjusted loss of 58 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-1.00.  The mean expectation of three analysts for the quarter was for a loss of 90 cents per share. Wall Street expected results to range from -100 cents to -80 cents per share.
Revenue rose 2.6% to $9.73 million from a year ago; analysts expected $9.91 million. 
Cytosorbents Corp's reported EPS for the quarter was a loss of 58 cents​.
The company reported a quarterly loss of $1.83 million.
Cytosorbents Corp shares had risen by 36.9% this quarter and lost 58.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 12.5% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" 
Wall Street's median 12-month price target for Cytosorbents Corp is $15.00, about 64.2% above its last closing price of $5.37
This summary was machine generated from LSEG data November 13 at 12:27 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Sep. 30 2026 
-0.90
-0.58
Beat
Jun. 30 2026 
-0.90
-1.40
Missed
Mar. 31 2026 
-1.10
-1.60
Missed
Dec. 31 2025 
-1.00
-1.80
Missed